Skip to content

Net margin at other companies

Abbott logo
AbbottABT
13.9%-18.0pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
21.8%-2.6pp
Boston Scientific logo
Boston ScientificBSX
17.3%+5.7pp
Medtronic logo
MedtronicMDT
13.2%-0.7pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9%+0.2pp
ITG
Integer HoldingsITGR
7.6%+3.2pp

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
Enterprise value$1.73B+48.1%
P/S2,391.5×

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Calculated from Pulse Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s net margin?
Pulse Biosciences, Inc. (PLSE) reported net margin of -9,929% in Q1 2026.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.